Blog

Dr. Overman Discusses Immunotherapy and MSI Testing in CRC – OncLive


OncLive

Dr. Overman Discusses Immunotherapy and MSI Testing in CRC
OncLive
Michael J. Overman, MD, associate professor, department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, discusses immunotherapy and microsatellite instability (MSI) testing in colorectal caner (CRC). In the

2018-02-08 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.